Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Optimization and clinical validation of a pathogen detection microarray
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
covidontheweb.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
has title
Optimization and clinical validation of a pathogen detection microarray
Creator
Kartasasmita, Cissy
Sung, Wing-Kin
Hibberd, Martin
Af, Eric
Heng, Wah
Lee, Charlie
Leong, Wan
Miller, Lance
Shirlena, W
Soh,
Wong, Christopher
Yee,
Source
Medline; PMC
abstract
DNA microarrays used as 'genomic sensors' have great potential in clinical diagnostics. Biases inherent in random PCR-amplification, cross-hybridization effects, and inadequate microarray analysis, however, limit detection sensitivity and specificity. Here, we have studied the relationships between viral amplification efficiency, hybridization signal, and target-probe annealing specificity using a customized microarray platform. Novel features of this platform include the development of a robust algorithm that accurately predicts PCR bias during DNA amplification and can be used to improve PCR primer design, as well as a powerful statistical concept for inferring pathogen identity from probe recognition signatures. Compared to real-time PCR, the microarray platform identified pathogens with 94% accuracy (76% sensitivity and 100% specificity) in a panel of 36 patient specimens. Our findings show that microarrays can be used for the robust and accurate diagnosis of pathogens, and further substantiate the use of microarray technology in clinical diagnostics.
has issue date
2007-05-28
(
xsd:dateTime
)
bibo:doi
10.1186/gb-2007-8-5-r93
bibo:pmid
17531104
has license
cc-by
sha1sum (hex)
40e94ea7aba6cfaed881217032da16d4a5c2fd1d
schema:url
https://doi.org/10.1186/gb-2007-8-5-r93
resource representing a document's title
Optimization and clinical validation of a pathogen detection microarray
has PubMed Central identifier
PMC1929155
has PubMed identifier
17531104
schema:publication
Genome Biol
resource representing a document's body
covid:40e94ea7aba6cfaed881217032da16d4a5c2fd1d#body_text
is
schema:about
of
named entity 'Volume 8'
named entity 'Open Access'
named entity 'Genome Biology'
named entity '2007'
named entity 'http'
named entity 'deposited'
named entity 'refereed'
named entity '2007'
named entity 'Genome Biology'
named entity 'microarray'
named entity 'Issue 5'
named entity 'R93'
named entity 'Issue 5'
named entity 'Genome Biology'
named entity 'Genome Biology'
named entity 'Genome Biology'
named entity 'Genome Biology'
named entity 'pathogen'
named entity 'R93'
named entity 'Open Access'
named entity 'Genome Biology'
named entity 'R93'
named entity 'R93'
named entity 'Issue 5'
named entity 'R93'
named entity 'Genome Biology'
named entity 'R93'
named entity 'microarray'
named entity 'Issue'
named entity '2007'
named entity '2007'
named entity 'deposited'
named entity 'Volume 8'
named entity 'Genome Biology'
named entity 'pathogen'
named entity 'Genome Biology'
named entity 'refereed'
named entity 'http'
named entity '2007'
named entity 'Issue'
named entity '2007'
named entity 'Genome Biology'
named entity 'Volume 8'
named entity 'Issue'
named entity 'Genome Biology'
named entity 'deposited'
named entity '2007'
named entity '2007'
named entity 'Optimization'
named entity 'refereed'
is
part of
of
Optimization and clinical validation of a pathogen detection microarray
DNA microarrays used as 'genomic sensors' have great potential in clinical diagnostics. Biases inherent in random PCR-amplification, cross-hybridization effects, and inadequate microarray analysis, however, limit detection sensitivity and specificity. Here, we have studied the relationships between viral amplification efficiency, hybridization signal, and target-probe annealing specificity using a customized microarray platform. Novel features of this platform include the development of a robust algorithm that accurately predicts PCR bias during DNA amplification and can be used to improve PCR primer design, as well as a powerful statistical concept for inferring pathogen identity from probe recognition signatures. Compared to real-time PCR, the microarray platform identified pathogens with 94% accuracy (76% sensitivity and 100% specificity) in a panel of 36 patient specimens. Our findings show that microarrays can be used for the robust and accurate diagnosis of pathogens, and further substantiate the use of microarray technology in clinical diagnostics.
covid:40e94ea7aba6cfaed881217032da16d4a5c2fd1d#body_text
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software